KRT88P and brain glioma: These results suggested that 131I‐A1094@RGD‐HBc, with extraordinary efficiency, specificity, and biocompatibility, could be developed as an ideal contrast agent for deep PAI and ultrasensitive SPECT imaging of orthotopic brain gliomas.